Publications by authors named "Ameer F Abbas Al Wssawi"
Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension.
Dalia D Hadi Mohammed Dheyaa Marsool Marsool Ali Dheyaa Marsool Marsool Neel Vora Sajjad G Al-Badri Ameer F Abbas Al Wssawi
Immun Inflamm Dis
November 2023
Article Synopsis
- Idiopathic pulmonary fibrosis (IPF) is a serious lung disease with no cure, causing irreversible lung scarring due to unknown genetic and environmental factors, and current treatments aim to slow progression and manage symptoms.
- Recent research explored new treatment options, including Saracatinib, which shows potential to be more effective than existing FDA-approved drugs for IPF, Pirfenidone and Nintedanib, and Sotatercept, which may help with pulmonary hypertension associated with the disease.
- This review highlights the potential for these advancements to improve IPF patient quality of life, but emphasizes the need for further studies to confirm their safety and efficacy.